An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor
Authors:
- 1 July 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 359 (2) , 285-291
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- N-Linked Glycosylation at Asn3and the Positively Charged Residues within the Amino-Terminal Domain of the C1 Inhibitor Are Required for Interaction of the C1 Inhibitor withSalmonella entericaSerovar Typhimurium Lipopolysaccharide and Lipid AInfection and Immunity, 2005
- Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2Journal of Experimental Medicine, 2003
- C1 Inhibitor Prevents Endotoxin Shock Via a Direct Interaction with LipopolysaccharideThe Journal of Immunology, 2003
- Essential role of MD-2 in LPS responsiveness and TLR4 distributionNature Immunology, 2002
- Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 GeneScience, 1998
- Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding ProteinJournal of Biological Chemistry, 1995
- Tumour necrosis factor alpha antibody protects against lethal meningococcaemiaMolecular Microbiology, 1992
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Human C.hivin.1 inhibitor: primary structure, cDNA cloning, and chromosomal localizationBiochemistry, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985